申请人:MECT CORPORATION
公开号:EP0386657A1
公开(公告)日:1990-09-12
An preparation for treating systemic lupus erythematosus containing the following compound:
wherein, when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium,
as an active ingredient and pharamacologically permittable carrier. The preparation of the present invention may be used in any administration method such as hypodermic, intramuscular and intravenous.
一种治疗系统性红斑狼疮的制剂,含有以下化合物:
其中,当 n 为 1 时,Z 代表氢、锂、钾、钠、铵或有机铵;当 n 为 2 时,Z 代表钙、钡或镁、
作为活性成分和药理学允许的载体。本发明制剂可用于皮下注射、肌肉注射和静脉注射等任何给药方法。